About Second Heart
Second Heart is a company based in Salt Lake City (United States) founded in 2015 by Jeff Donofrio and Howard Leonhardt. Second Heart has raised $33.98 million across 3 funding rounds from investors including Patel Property Investments. Second Heart offers products and services including Whisper and Freedom. Second Heart operates in a competitive market with competitors including Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.
- Headquarter Salt Lake City, United States
- Founders Jeff Donofrio, Howard Leonhardt
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Second Heart Assist Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$33.98 M (USD)
in 3 rounds
-
Latest Funding Round
$14.67 M (USD), Series C
Dec 31, 2021
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Second Heart
Second Heart offers a comprehensive portfolio of products and services, including Whisper and Freedom.
Provides mechanical circulatory support for heart failure patients in clinical trials.
Offers chronic heart support through wireless technology for improved function.
People of Second Heart
Unlock access to complete
Unlock access to complete
Funding Insights of Second Heart
Second Heart has successfully raised a total of $33.98M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $14.67 million completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Second Heart
Second Heart has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Patel Property Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A real estate investment enterprise focused on property deals.
|
Locked | Locked | Locked |
Investor details for Second Heart
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Second Heart
Investment portfolio details for Second Heart
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Second Heart
Detailed financials for Second Heart
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Second Heart Comparisons
Peer comparison for Second Heart
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Second Heart
Second Heart operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Implantable battery-powered pumps for ascites removal are developed.
|
|
| Locked | Locked | Locked |
Implantable technology for hypertension and heart failure is developed.
|
|
| Locked | Locked | Locked |
Miniaturized ventricular assist devices are developed for heart failure treatment.
|
|
| Locked | Locked | Locked |
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
|
|
| Locked | Locked | Locked |
Minimally invasive ventriculoplasty system for heart failure and FMR
|
|
| Locked | Locked | Locked |
Total artificial hearts are developed for cardiac replacement therapy.
|
Detailed competitors of Second Heart
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Second Heart
Complete news archive for Second Heart
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Second Heart
Second Heart was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Second Heart is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.
Jeff Donofrio is the current CEO of Second Heart. They have also founded this company.
Second Heart is a funded company, having raised a total of $33.98M across 3 funding rounds to date.
Second Heart was founded in 2015 in Salt Lake City, United States, within the medical device sector focused on cardiovascular care. A proprietary aortic stent pump technology is utilized to create a circulatory support platform, deployed through low-profile catheter-based methods. An initial temporary assist pump is targeted for acute decompensated heart failure patients and high-risk percutaneous coronary interventions. A subsequent wirelessly powered device is intended for chronic heart failure support.
Second Heart's top competitors include Sequana Medical, CVRx and Adona Medical.
Second Heart offers Whisper and Freedom.
Second Heart has 1 investor. Key investors include Patel Property Investments.